BioSpace News Archive

CARsgen Therapeutics, a clinical-stage company committed to developing Chimeric Antigen Receptor T cell therapies for cancer, announced appointment of Yong Fan, MD, as Senior Vice President, Global Regulatory Affairs.

United Therapeutics Corporation announced that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company’s business at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, California.

TOMi Scope allows physicians, for the first time ever, to non-invasively view fluid directly in the middle ear, even in the presence of wax build-up

Emergent BioSolutions Inc. announced that members of the company’s executive management team will participate in the following investor conferences during the first quarter of 2020

Osmotica Pharmaceuticals plc, a fully integrated biopharmaceutical company, announced the commencement of a proposed public offering of 6,000,000 ordinary shares.

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today provided a year-end corporate update.

Orchard Therapeutics (Nasdaq: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovative gene therapies, today announced that the company is scheduled to present at the 38th Annual J.P. Morgan Healthcare Conference

LHC Group, Inc. announced that it has finalized joint venture purchase and expansion agreements with partners in Texas, Arkansas, and Louisiana – all effective as of January 1, 2020.

Clearside Biomedical, Inc., a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced that the Company will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Thursday, January 16, 2020 at 11:30 a.m. PT.

Antengene Corporation today announced its appointment of Mr. John Chin, MBA, as Chief Business Officer (CBO).